Cart
sales@molnova.com
Salicylamide
CAS No. 65-45-2
Salicylamide( Salicylamide | Acket | Allevin | Benesal | Cymidon | Dropsprin | Eggosalil | Panithal | Salizell | Urtosal )
Catalog No. M15487 CAS No. 65-45-2
Salicylamide is the common name for the substance o-hydroxybenzamide, or amide of salicyl.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 43 | In Stock |
|
Biological Information
-
Product NameSalicylamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionSalicylamide is the common name for the substance o-hydroxybenzamide, or amide of salicyl.
-
DescriptionSalicylamide is the common name for the substance o-hydroxybenzamide, or amide of salicyl. Salicylamide is a non-prescription drug with analgesic and antipyretic properties. Its medicinal uses are similar to those of aspirin. Salicylamide is used in combination with both aspirin and caffeine in the over-the-counter pain remedies.(In Vitro):Treatment with salicylamides leads to the bacterial growth inhibition which correlates with the level of inhibition of sulfate reduction.(In Vivo):Salicylamide administration decreases the levels of radiosulfate in maternal serum and placenta, and impaires the incorporation of radiosulfate into fetal skeletal GAGs. Salicylamide administration results in a decrease in the calcium content of fetal limb bones, but has no significant effect on maternal serum calcium. Salicylamide administration decreases radiosulfate uptake by maternal serum and liver, fetus and placenta--effects being dose-dependent. Differences in radiosulfate uptake by the fetus and placenta over time, induced by salicylamide, are also significant independently of maternal serum levels of radiosulfate.
-
In VitroTreatment with salicylamides leads to the bacterial growth inhibition which correlates with the level of inhibition of sulfate reduction.
-
In VivoSalicylamide administration decreases the levels of radiosulfate in maternal serum and placenta, and impaires the incorporation of radiosulfate into fetal skeletal GAGs. Salicylamide administration results in a decrease in the calcium content of fetal limb bones, but has no significant effect on maternal serum calcium. Salicylamide administration decreases radiosulfate uptake by maternal serum and liver, fetus and placenta--effects being dose-dependent. Differences in radiosulfate uptake by the fetus and placenta over time, induced by salicylamide, are also significant independently of maternal serum levels of radiosulfate.
-
SynonymsSalicylamide | Acket | Allevin | Benesal | Cymidon | Dropsprin | Eggosalil | Panithal | Salizell | Urtosal
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX-1| COX-2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number65-45-2
-
Formula Weight137.14
-
Molecular FormulaC7H7NO2
-
Purity>98% (HPLC)
-
Solubilitysoluble in Water
-
SMILESO=C(N)C1=CC=CC=C1O
-
Chemical Name2-Hydroxybenzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Manin AN, et al. J Phys Chem B. 2014 Jun 19;118(24):6803-14.
molnova catalog
related products
-
6-paradol
6-paradol is a pungent phenolic substance found in ginger and other Zingiberaceae plants and exhibits a variety of biological activities including anti-cancer anti-inflammatory and anti-oxidative activitiesneuroprotective Effects.
-
Agnuside
Agnuside inhibits COX-2 (IC50: 0.026 mg/ml) but exhibits less than 10% inhibition of COX-1 at this concentration. It also inhibits 46.3 66.8 and 82.1% of P-glycoprotein (P-gp) ATPase activity at concentrations of 5 25 and 100 μM respectively.
-
Firocoxib
Firocoxib is a selective non-steroidal inhibitor of cycooxygenase-2 (COX-2) (IC50 of 0.13 μM), with anti-inflammatory for use in dogs and horses.
